OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
21
Results
Show all
Save search
Copy query
Show results for
Unknown
(21)
Publication Date
Release Date
2022
(5)
2024
(3)
2016
(3)
2021
(2)
2025
(1)
2023
(1)
2020
(1)
2019
(1)
2015
(1)
2014
(1)
2012
(1)
2008
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
An Algerian Soil-Living
Streptomyces alboflavus
Strain as Source of Antifungal Compounds for the Management of the Pea Pathogen
Fusarium oxysporum
f. sp.
pisi
.
Not available
S-EPMC11596007
|
biostudies-literature
Cite
Pea-Wheat Rotation Affects Soil Microbiota Diversity, Community Structure, and Soilborne Pathogens.
Not available
S-EPMC8876268
|
biostudies-literature
Cite
PED/PEA-15 induces autophagy and mediates TGF-beta1 effect on muscle cell differentiation.
Not available
S-EPMC3374077
|
biostudies-literature
Cite
Parkinson-like phenotype in insulin-resistant PED/PEA-15 transgenic mice.
Not available
S-EPMC4947959
|
biostudies-literature
Cite
Palmitoylethanolamide Reduces Colon Cancer Cell Proliferation and Migration, Influences Tumor Cell Cycle and Exerts In Vivo Chemopreventive Effects.
Not available
S-EPMC8073478
|
biostudies-literature
Cite
Molecular cloning and characterization of the human PED/PEA-15 gene promoter reveal antagonistic regulation by hepatocyte nuclear factor 4alpha and chicken ovalbumin upstream promoter transcription factor II.
Not available
S-EPMC2662169
|
biostudies-literature
Cite
Merging genotyping-by-sequencing data from two ex situ collections provides insights on the pea evolutionary history.
Not available
S-EPMC8935929
|
biostudies-literature
Cite
Palmitoylethanolamide Promotes White-to-Beige Conversion and Metabolic Reprogramming of Adipocytes: Contribution of PPAR-α.
Not available
S-EPMC8880285
|
biostudies-literature
Cite
Palmitoylethanolamide normalizes intestinal motility in a model of post-inflammatory accelerated transit: involvement of CB₁ receptors and TRPV1 channels.
Not available
S-EPMC4243976
|
biostudies-literature
Cite
Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing-Remitting Multiple Sclerosis.
Not available
S-EPMC4824021
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets